Shonan Health Innovation Park (Shonan iPark) began operations in April 2018, with the aim of creating a co-location ecosystem comprised of researchers, industry experts, venture startups, government, and academia who will collaborate and co-create - to accelerate research, with the aim of transforming cutting-edge science into impactful health solutions for patients across the world.
In today’s environment, the speed of innovation is being accelerated and new technological applications are realized each day. At the same time, the hurdles companies face to bring innovative therapies to markets continue to rise. Also, in Japan, basic life science research is not smoothly connected to practice causing a disconnect when it comes to translating technologies into applications for patients. Shonan iPark was designed to overcome these challenges by providing an open innovation environment where it is possible to continuously network and share ideas, to celebrate successes and learn from failures.
Takeda Pharmaceutical Company launched Shonan iPark by transforming its Shonan research site to enhance scientific innovation with the aspiration to become a world-class ecosystem. Shonan iPark is supported by the local government and aligns well with the backbone of the government’s economic and revitalization strategy.
We welcome aspirational entrepreneurs and researchers to make iPark their home. Let's work together to open a new era of science, build a new success model of researcher, and create the world-leading science park!
General Manager of Shonan iPark
Toshio Fujimoto is the General Manager of Shonan Health Innovation Park (iPark) since April 2018. In his current role, Dr. Fujimoto provides strategic leadership and oversight for all key iPark activities. He implements the iPark’s vision to be an open innovation ecosystem which builds meaningful collaborations with academia, biotech, pharma companies, and the government.
Dr. Fujimoto received his MD from Kyoto University and his MBA from Kobe University. He began his clinical practice as a Resident at the Department of Thoracic Surgery at Kyoto University Hospital. After completing several rotations at local area hospitals, he took a position in Germany as an Assistant Surgeon with the Thoracic Surgery Department at Ruhrlandklink Hospital, and later moved to the U.S. to serve as Clinical Fellow, General Thoracic Surgery at the Mayo Clinic.
Prior to joining Shonan iPark, Dr. Fujimoto held positions with increasing responsibility at Eli Lilly Japan. Most recently he was Vice President of the Medicine Development Unit, where he oversaw the R&D Management function in Japan.